breast cancer

envie a um amigo share this

Immunosensor for the analysis HER2 ECD

An electrochemical immunosensor for the analysis of HER2 ECD in human serum samples was developed. To achieve this goal a screen-printed carbon electrode, modified with gold nanoparticles, was used as transducer surface. A sandwich immunoassay, using two monoclonal antibodies, was employed and the detection of the antibody-antigen interaction was performed through the analysis of an enzymatic reaction product by linear sweep voltammetry. The calibration curve was established between 15 and 100 ng/mL and a limit of detection of 4.4 ng/mL was achieved.

Geographical variations in breast cancer epidemiology

Authors and Affiliations: 
Maria do Rosário André*, Sandra Amaral*, Alexandra Mayer**, Ana Miranda**, ROR-SUL Working Group**
* Departamento de Oncologia Médica, Instituto Português de Oncologia de Lisboa Francisco Gentil. 
** Registo Oncologico Regional - Sul (ROR-SUL), Instituto Português de Oncologia de Lisboa Francisco Gentil
 
Abstract:
Objectives: Although the breast cancer incidence in Portugal is lower than the European average, it is the most frequent cancer in
w

Fatty acid and phospholipid biosynthetic pathways are regulated throughout mammary epithelial cell differentiation and correlate to breast cancer survival

Authors and Affiliations:

M. Luísa Dória*1, Ana S. Ribeiro*1, Jun Wang2, Cândida Z. Cotrim1, Pedro Domingues1, Cecilia Williams2, M. Rosário Domingues1 and Luisa A. Helguero1

1Mass Spectrometry Centre, Organic Chemistry and Natural Products Research Unit, Department of Chemistry, Universidade de Aveiro, Campus de Santiago, Aveiro, Portugal; and

First international consensus guidelines for breast cancer in young women (BCY1)

Authors and Affiliations:
Partridge AH1, Pagani O2, Abulkhair O3, Aebi S4, Amant F5, Azim HA Jr6, Costa A7, Delaloge S8, Freilich G9, Gentilini OD10, Harbeck N11, Kelly CM12, Loibl S13, Meirow D14, Peccatori F15, Kaufmann B16, Cardoso F17.

1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

First international consensus guidelines for breast cancer in young women (BCY1)

Autores e Afiliações:
Partridge AH1, Pagani O2, Abulkhair O3, Aebi S4, Amant F5, Azim HA Jr6, Costa A7, Delaloge S8, Freilich G9, Gentilini OD10, Harbeck N11, Kelly CM12, Loibl S13, Meirow D14, Peccatori F15, Kaufmann B16, Cardoso F17.

1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

A new link between P-cadherin and α6β4-integrin with implications in breast cancer progression

Researchers at IPATIMUP (Joana Paredes group) are focused in P-cadherin, an adhesion molecule that induces cancer stem cell and invasive properties in breast cancer. In its newest publication, this group found a downstream signaling pathway that helps clarify P-cadherin mediated aggressive effects.

This work reports an important crosstalk between P-cadherin and the laminin receptor α6β4, a link that was never previously described. The activation of this heterodimer points to a new molecular mechanism that may be targeted to counteract the effects induced by this adhesion molecule.

Inhibition of lactate efflux as strategy of breast cancer treatment

Authors and Affiliations:

Filipa Morais-Santos1,2, Vera Miranda-Gonçalves1,2, Sílvia Pinheiro1,2, André F Vieira3, Joana Paredes3, Fernando C Schmitt3,4,5,6, Fátima Baltazar1,2,* and Céline Pinheiro1,2,7,*

1 School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal

2 ICVS/3B’s – PT Government Associate Laboratory, Braga, Guimarães, Portugal

Associação Laço launches 2nd edition of a Research Grant in breast cancer

With the aim of encouraging new scientific discoveries to help find cancer causes and to reduce its incidence, as well as
the mechanisms that trigger metastatic breast cancer, the Association will fund a 25 thousand euros research grant. Applications are open from October 30, national day for breast cancer prevention, to  January 31st 2014.

Breast Cancer: relevance of low molecular weight protein tyrosines phosphatase isoforms

Low-molecular weight protein tyrosine phosphatase (LMW-PTP) has been associated with tumorigenesis and tumor progression. However, its role remains controversial. In this study we demonstrate that the controversial role of this protein can be due to the paucity of studies focused on its two main isoforms, fast and slow. The differential expression of these isoforms should be taken into account when studying this protein in the context of tumor, namely breast cancer. Our results highlight the role of these isoforms in breast cancer.

Authors and affiliations:

Progesterone receptor targeting with radiolabelled steroids in breast cancer

Authors and affiliations:

Susana Cunha1, Lurdes Gano1, Goreti Ribeiro Morais1, Thies Thiemann2 and Maria Cristina Oliveira1*

 

1 Unidade de Ciências Químicas e Radiofarmacêuticas, Campus Tecnológico e Nuclear

Instituto Superior Técnico, Universidade Técnica de Lisboa

Estrada Nacional 10 ao km 139,7

2695-066 Bobadela LRS, Portugal

2 Faculty of Science, United Arab Emirates University, United Arab Emirates

 

Abstract: